The following are recent press releases from Focus Diagnostics. Click on the name to view the entire release.
September 9, 2008
Focus Diagnostics Receives FDA 510(k) Clearance for Two Plexus™ Test Kits for Detecting Epstein-Barr Virus Antibodies
February 15, 2008
Focus Diagnostics Launches Laboratory Test for Chikungunya Virus
November 2007
Plexus™ Software receives FDA 510K clearance
October 30, 2007
HerpeSelect Express rapid HSV serology test receives FDA 510K clearance
September 20, 2007
Focus Diagnostics receives NYSDOH exemption for Diagnostic Immunology and Serology testing services
March 5, 2007
Focus Diagnostics receives FDA Clearance to Market Plexus™ HerpeSelect®
July 5, 2006
Quest Diagnostics Completes Acquisition of Focus Diagnostics, Inc., a World Leader in Infectious Disease Testing
May 19, 2006
Quest Diagnostics to Acquire Focus Diagnostics, Inc., A World Leader in Infectious Disease Testing
February 10, 2006
Focus Diagnostics announces Coccidioides DxSelect&trade, a new total antibody (IgG, IgA, and IgM) screening ELISA coccidiomycosis
November 3, 2005
Focus Diagnostics Announces Release Of GenomEx™ Genetic Interpretive Services
September 12, 2005
Announcing a license agreement with Primagen Holding, B.V., to develop PCR detection for human coronavirus NL63.
June 21, 2005
Focus Diagnostics Signs Referral Testing Agreement with Child Health Corporation ofAmerica
June 6, 2005
Focus Diagnostics Enters Into New Agreement with Luminex Corporation For the Development of In Vitro Diagnostic Products
May 10, 2005
Focus Diagnostics Receives Patent on Fungal ELISA Method
May, 2005
Jean Amos Wilson, Ph.D., joins Focus Diagnostics' Reference Laboratory
April 14, 2005
British Biocell International and Focus Diagnostics Sign Exclusive Distribution Agreement For New HSV-2 Point-Of-Care Product
April, 2005
Ken Van Horn,Ph.D., joins Focus Diagnostics' Reference Laboratory
January 12, 2005
Focus Announces Corporate Name Change to Focus Diagnostics
December 22,2003
Focus Technologies and Bio-Inova Create Global Central Laboratory Capability
December 8, 2003
Frost & Sullivan Commends Focus Technologies for its Novel Testing Methodologies to Combat Rare and Emerging Diseases
October 27, 2003
Focus Technologies announced today FDA clearance of its IgM and IgG ELISA antibody detection diagnostic kits
October 3, 2003
Focus Technologies is First Laboratory to offer Human Metapneumovirus (hMPV)Testing
July 28, 2003
Focus Technologies Becomes First US Laboratory To License ViroNovative’s Human Metapneumovirus
May 12, 2003
Robert Flamm, Ph.D. Joins Focus Technologies’ Anti-Infective Services Team
May 1, 2003
Focus Technologies Offers First Commerical Laboratory Test for Severe Acute Respiratory Syndrome (SARS)
April 7, 2003
Focus Technologies' Infectious Disease Laboratory Receives ISO 9001 Certification
March 31, 2003
Dr. Jan Groen Joins Focus Technologies' Reference Laboratory
May 13, 2002
CDC STD Treatment Guidelines Promote HSV Type-Specific Tests
